Skip to main navigation Skip to search Skip to main content

Author Correction: Clinical Implications of Sub-grouping HER2 Positive Tumors by Amplicon Structure and Co-amplified Genes (Scientific Reports, (2019), 9, 1, (18795), 10.1038/s41598-019-55455-6)

  • Myriam Maoz
  • , Michal Devir
  • , Michal Inbar
  • , Ziva Inbar-Daniel
  • , Dana Sherill-Rofe
  • , Idit Bloch
  • , Karen Meir
  • , David Edelman
  • , Salah Azzam
  • , Hovav Nechushtan
  • , Ofra Maimon
  • , Beatrice Uziely
  • , Luna Kadouri
  • , Amir Sonnenblick
  • , Amir Eden
  • , Tamar Peretz
  • , Aviad Zick*
  • *Corresponding author for this work

Research output: Contribution to journalComment/debate

Abstract

A supplementary file containing Tables S1, S2 and S3 was omitted from the original version of this Article. This has been corrected in the HTML version of the Article; the PDF version was correct at time of publication.

Original languageEnglish
Article number3941
JournalScientific Reports
Volume10
Issue number1
DOIs
StatePublished - 1 Dec 2020

Bibliographical note

Publisher Copyright:
© 2020, The Author(s).

Fingerprint

Dive into the research topics of 'Author Correction: Clinical Implications of Sub-grouping HER2 Positive Tumors by Amplicon Structure and Co-amplified Genes (Scientific Reports, (2019), 9, 1, (18795), 10.1038/s41598-019-55455-6)'. Together they form a unique fingerprint.

Cite this